AAAAAA
Results:
1-21
|
Results: 21
Authors:
Indrova, M
Bubenik, J
Simova, J
Vonka, V
Nemeckova, S
Mendoza, L
Reinis, M
Citation: M. Indrova et al., Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines:In vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide, INT J MOL M, 7(1), 2001, pp. 97-100
Authors:
Indrova, M
Bubenik, J
Simova, J
Bieblova, J
Jandlova, T
Smahel, M
Vonka, V
Glazman-Kusnierczyk, H
Pajtasz-Piasecka, E
Radzikowski, C
Mikyskova, R
Citation: M. Indrova et al., Chemoimmunotherapy of cancer: Potentiated effectiveness of granulocyte-macrophage colony-stimulating factor and ifosfamide derivative CBM-4A, ONCOL REP, 8(6), 2001, pp. 1371-1374
Authors:
Bubenik, J
Citation: J. Bubenik, Genetically engineered dendritic cell-based cancer vaccines (review), INT J ONCOL, 18(3), 2001, pp. 475-478
Authors:
Mikyskova, R
Bubenik, J
Mendoza, L
Vonka, V
Smahel, M
Simova, J
Jandlova, T
Citation: R. Mikyskova et al., Local cytokine treatment of HPV16-associated tumours results in inhibitionof their lung metastases, CLIN EXP M, 18(7), 2001, pp. 581-587
Authors:
Bubenik, J
Citation: J. Bubenik, Utilization of oncoprotein-pulsed dendritic cells as tumor vaccines, J CANC RES, 127(8), 2001, pp. 463-466
Authors:
Bubenik, J
Citation: J. Bubenik, Genetically modified dendritic cell-based cancer vaccines, FOL BIOL, 47(5), 2001, pp. 153-155
Authors:
Smahel, M
Sobotkova, E
Bubenik, J
Simova, J
Zak, R
Ludvikova, V
Hajkova, R
Kovarik, J
Jelinek, F
Povysil, C
Marinov, J
Vonka, V
Citation: M. Smahel et al., Metastatic MHC class I-negative mouse cells derived by transformation withhuman papillomavirus type 16, BR J CANC, 84(3), 2001, pp. 374-380
Authors:
Vlk, V
Eckschlager, T
Kavan, P
Kabickova, E
Koutecky, J
Sobota, V
Bubenik, J
Pospisilova, D
Citation: V. Vlk et al., Clinical ineffectiveness of IL-2 and/or IFN alpha administration after autologous PBSC transplantation in pediatric oncological patients, PED HEM ONC, 17(1), 2000, pp. 31-44
Authors:
Bubenik, J
Den Otter, W
Huland, E
Citation: J. Bubenik et al., Local cytokine therapy of cancer: interleukin-2, interferons and related cytokines, CANCER IMMU, 49(2), 2000, pp. 116-122
Authors:
Bubenik, J
Citation: J. Bubenik, Tomas Hraba (1928-2000) - In memoriam, FOL BIOL, 46(5), 2000, pp. 161-161
Authors:
Bubenik, J
Citation: J. Bubenik, Cross-contamination of cell lines in culture, FOL BIOL, 46(5), 2000, pp. 163-164
Authors:
Sobota, V
Bubenik, J
Simova, J
Jandlova, T
Citation: V. Sobota et al., Intratumoral IL-2 gene transfer improves the therapeutic efficacy of IL-12but not IL-18, FOL BIOL, 46(5), 2000, pp. 191-193
Authors:
Mendoza, L
Indrova, M
Hajkova, R
Reinis, M
Smahel, M
Vonka, V
Bubenik, J
Jandlova, T
Citation: L. Mendoza et al., Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth, FOL BIOL, 46(3), 2000, pp. 91-97
Authors:
Simova, J
Reinis, M
Sobota, V
Capkova, J
Bubenik, J
Jandlova, T
Citation: J. Simova et al., Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80, molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines, FOL BIOL, 46(1), 2000, pp. 11-15
Authors:
Sobota, V
Indrova, M
Rossner, P
Bubenik, J
Jandlova, T
Citation: V. Sobota et al., CD80 and IL-2 signals cooperate in the regression of tumors transplanted in congenitally athymic mice, ONCOL REP, 6(3), 1999, pp. 669-673
Authors:
Bubenik, J
Simova, J
Hajkova, R
Sobota, V
Jandlova, T
Smahel, M
Sobotkova, E
Vonka, V
Citation: J. Bubenik et al., Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16, INT J ONCOL, 14(3), 1999, pp. 593-597
Authors:
Hajkova, R
Indrova, M
Jandlova, T
Bubenik, J
Reinis, M
Citation: R. Hajkova et al., Interleukin 2 gene therapy of surgical minimal residual tumour disease: Characterization of cytolytic effector cells from tumour progressors and regressors, FOL BIOL, 45(6), 1999, pp. 227-231
Authors:
Rossner, P
Bubenik, J
Sobota, V
Indrova, M
Hajkova, R
Mendoza, L
Jandlova, T
Simova, J
Citation: P. Rossner et al., Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines, FOL BIOL, 45(5), 1999, pp. 173-177
Authors:
Bubenik, J
Citation: J. Bubenik, Granulocyte-macrophage colony-stimulating factor gene-modified vaccines for immunotherapy of cancer, FOL BIOL, 45(4), 1999, pp. 115-119
Authors:
Bubenik, J
Citation: J. Bubenik, Dendritic cell-based cancer vaccines, FOL BIOL, 45(3), 1999, pp. 71-74
Authors:
Indrova, M
Pajtasz-Piasecka, E
Jandlova, T
Simova, J
Bubenik, J
Radzikowski, C
Citation: M. Indrova et al., IL-2 gene-modified tumour vaccines: Monitoring of IL-2 levels in serum andperitoneal cavity of vaccinated mice, FOL BIOL, 45(1), 1999, pp. 7-11
Risultati:
1-21
|